Women’s attitude toward gynecological pain in fertile age: Results from a cross-sectional study among Italian community pharmacies

Abstract

Introduction:

Several epidemiological data on women afferent to clinics for medical treatment of pelvic pain are available, while few studies explored the general population. Thus, this study aimed to investigate women presenting with gynecological pain at the community pharmacy and to evaluate the relevance of pharmacist advice regarding medical treatment.

Methods:

A cross-sectional study was conducted in a sample of 10 Italian community pharmacies, by administering a structured questionnaire to fertile age women reporting pelvic pain during the last 3 months. Questions were concerning demographic information, pain characteristics, women’s behavior toward gynecological pain, and diagnosis possibly received from a physician.

Results:

A group of 290 women were interviewed. Severe pain was reported in 58.3%, with a mean ± SD of 4.4 ± 6.8 days of suffering, causing absenteeism from work in 45.3% of cases. Almost half of women reported that the onset of gynecological pain was before 15 years and 72.2% had consulted a physician in the past, with a mean delay of 2.5 ± 4.3 years between the onset of pain and medical consultation. However, only 28% of the overall population received a diagnosis. 51.0% received one treatment, while 39% received two or more. The first therapy was prescribed in 40.2% cases by the physician, while in the remaining it was recommended either by the pharmacist or it was a self-medication.

Conclusion:

Gynecological pelvic pain is a disabling problem, regardless of the underlying cause, with significant impact on social and working life and requiring a better medical management.

Keywords

Community pharmacy dysmenorrhea fertile age medical treatment non-steroidal anti-inflammatory drugs pelvic pain

Get full access to this article

View all access options for this article.

References

Steege

Siedhoff

. Chronic pelvic pain. Obstet Gynecol 2014; 124(3): 616–629.

Newham

van der Spuy

Nugent

. Laparoscopic findings in women with chronic pelvic pain. S Afr Med J 1996; 86(9 Suppl.): 1200–1203.

Jones

Kennedy

Jenkinson

. Health-related quality of life measurement in women with common benign gynecologic conditions: a systematic review. Am J Obstet Gynecol 2002; 187(2): 501–511.

Kumar

Elavarasi

. Definition of pain and classification of pain disorders. J Adv Clin Res Insights 2016; 3: 87–90.

ACOG. ACOG practice bulletin no. 51. Chronic pelvic pain. Obstet Gynecol 2004; 103(3): 589–605.

Patel

Tanksale

Sahasrabhojanee

et al . The burden and determinants of dysmenorrhoea: a population-based survey of 2262 women in Goa, India. BJOG 2006; 113(4): 453–463.

Bernardi

Lazzeri

Perelli

et al . Dysmenorrhea and related disorders. F1000Res 2017; 6: 1645.

Fletcher

Zimmern

. Differential diagnosis of chronic pelvic pain in women: the urologist’s approach. Nat Rev Urol 2009; 6(10): 557–562.

Graziottin

Gambini

Bertolasi

. Genital and sexual pain in women. Handb Clin Neurol 2015; 130: 395–412.

10.

Iacovides

Avidon

Baker

. What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update 2015; 21(6): 762–778.

11.

Proctor

Farquhar

. Diagnosis and management of dysmenorrhoea. Br Med J 2006; 332(7550): 1134–1138.

12.

Luisi

Lazzeri

Ciani

et al . Endometriosis in Italy: from cost estimates to new medical treatment. Gynecol Endocrinol 2009; 25(11): 734–740.

13.

Grandi

Ferrari

Xholli

et al . Prevalence of menstrual pain in young women: what is dysmenorrhea? J Pain Res 2012; 5: 169–174.

14.

Nishikitani

Nakao

Tsurugano

et al . Relationship between menstruation status and work conditions in Japan. Biopsychosoc Med 2017; 11(1): 26.

15.

Al-Jefout

Seham

A-F

Jameel

et al . Dysmenorrhea: prevalence and impact on quality of life among young adult Jordanian females. J Pediatr Adolesc Gynecol 2015; 28(3): 173–185.

16.

Jung

Lee

. The effectiveness of an educational intervention on proper analgesic use for dysmenorrhea. Eur J Obstet Gynecol Reprod Biol 2013; 170(2): 480–486.

17.

Marjoribanks

Ayeleke

Farquhar

et al . Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev 2015; 7: CD001751.

18.

Staal

AHJ

Van Der Zanden

Nap

. Diagnostic delay of endometriosis in the Netherlands. Gynecol Obstet Invest 2016; 81(4): 321–324.

19.

Van Der Zanden

Nap

. Knowledge of, and treatment strategies for, endometriosis among general practitioners. Reprod Biomed Online 2016; 32(5): 527–531.

20.

Ballard

Lowton

Wright

. What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis. Fertil Steril 2006; 86(5): 1296–1301.

21.

Yosef

Ahmed

Al-Hussaini

et al . Chronic pelvic pain: pathogenesis and validated assessment. Middle East Fertil Soc J 2016; 21(4): 205–221.

22.

De Graaff

D’hooghe

Dunselman

GAJ

et al . The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey. Hum Reprod 2013; 28(10): 2677–2685.

23.

Nnoaham

Hummelshoj

Webster

et al . Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril 2011; 96(2): 366–373.e8.

24.

Harlow

Campbell

OMR

. Epidemiology of menstrual disorders in developing countries: a systematic review. BJOG 2004; 111(1): 6–16.

25.

Latthe

Say

et al . WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. BMC Public Health 2006; 6: 177.

26.

Subasinghe

Happo

Jayasinghe

et al . Prevalence and severity of dysmenorrhoea, and management options reported by young Australian women. Aust Fam Physician 2016; 45(11): 829–834.

27.

Breivik

Borchgrevink

Allen

et al . Assessment of pain. Br J Anaesth 2008; 101(1): 17–24.

28.

Jones

Mishra

. The prevalence and risk factors of dysmenorrhea. Epidemiol Rev 2014; 36(1): 104–113.

29.

Habibi

Huang

MSL

Gan

et al . Prevalence of primary dysmenorrhea and factors associated with its intensity among undergraduate students: a cross-sectional study. Pain Manag Nurs 2015; 16(6): 855–861.

30.

De Sanctis

Soliman

Bernasconi

et al . Primary dysmenorrhea in adolescents: prevalence, impact and recent knowledge. Pediatr Endocrinol Rev 2015; 13(2): 512–520.

31.

Parker

Sneddon

Arbon

. The menstrual disorder of teenagers (MDOT) study: determining typical menstrual patterns and menstrual disturbance in a large population-based study of Australian teenagers. BJOG an Int J Obstet Gynaecol 2010; 117(2): 185–192.

32.

Brown

Hewitt

. Chronic pelvic pain and recurrent abdominal pain in female adolescents. Endocr Dev 2004; 7: 213–224.

33.

Stones

Price

. Health services for women with chronic pelvic pain. J R Soc Med 2002; 95(11): 531–535.

34.

Zondervan

Yudkin

Vessey

et al . The community prevalence of chronic pelvic pain in women and associated illness behaviour. Br J Gen Pract 2001; 51(468): 541–547.

35.

Casper

. Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills. Fertil Steril 2017; 107(3): 533–536.

36.

Ryan

. The treatment of dysmenorrhea. Pediatr Clin North Am 2017; 64(2): 331–342.

37.

Evans

Sutton

. Oral contraception. Med Clin North Am 2015; 99(3): 479–503.

38.

Petraglia

Hornung

Seitz

et al . Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Arch Gynecol Obstet 2012; 285(1): 167–173.

39.

Sabbioni

Petraglia

Luisi

. Non-contraceptive benefits of intrauterine levonorgestrel administration: why not? Gynecol Endocrinol 2017; 33(11): 822–829.